Suppliers in Medford, NY
10 Medicare Suppliers found. Showing 1 - 10
 |
Cvs Pharmacy #17065 Durable Medical Equipment & Medical Supplies Location: 2975 Horseblock Rd, Medford, New York 11763 Phone: (631) 286-1854 |
|
Rite Aid Pharmacy #10649 Durable Medical Equipment & Medical Supplies Location: 2799 Route 112, Medford, New York 11763 Phone: (631) 758-2800 |
Rite Aid Pharmacy #10650 Durable Medical Equipment & Medical Supplies Location: 700 Patchogue Yaphank Rd, Medford, New York 11763 Phone: (631) 345-0535 |
|
Sam's Pharmacy 106428 Durable Medical Equipment & Medical Supplies Location: 2950 Horseblock Rd, Medford, New York 11763 Phone: (631) 286-8497 |
Stop & Shop Pharmacy #583 Durable Medical Equipment & Medical Supplies Location: 70030 Patchogue Yaphank Rd, Medford, New York 11763 Phone: (631) 345-0255 |
Walgreens #11209 Durable Medical Equipment & Medical Supplies Location: 2850 Route 112, Medford, New York 11763 Phone: (631) 696-4018 |
Walgreens #4687 Durable Medical Equipment & Medical Supplies Location: 1580 Route 112, Medford, New York 11763 Phone: (631) 207-9234 |
News Archive
Streamlining medical coverage could save costs associated with pediatric obesity
Pediatric obesity ends up costing $3 billion annually in the U.S., but a significant amount of that could be saved by streamlining medical coverage to address health issues affecting young obese patients now rather than waiting to treat conditions they develop as they get older, according UCLA researchers and colleagues.
Significant new breakthroughs in understanding how the genes in mammals are controlled
An international consortium of genome research institutes and investigators, including Jackson Laboratory Staff Scientists Carol J. Bult, Ph.D., and Martin Ringwald, Ph.D., has reported significant new breakthroughs in understanding how the genes in mammals are controlled.
European CHMP issues positive opinion for Roche's Tarceva as maintenance therapy for NSCLC
Roche today announced that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for use of Tarceva(R) (erlotinib) as a maintenance therapy for people with advanced non-small cell lung cancer (NSCLC) and stable disease (cancer remains largely unchanged) after initial chemotherapy. The CHMP positive opinion clears the way for European Union approval and means that this group of patients may soon be able to benefit from earlier treatment with Tarceva.
Study finds increased risk of cancers among rescue/recovery workers after WTC terrorist attack
Among rescue and recovery workers exposed to the dust, debris, and fumes following the World Trade Center terrorist attack, there was an increased incidence of prostate and thyroid cancers and multiple myeloma, although it is not clear how big a factor medical screening and non-WTC risk factors contributed to these increases, according to a study in the December 19 issue of JAMA.
› Verified 3 days ago